Skip to main content
Fig. 4 | BMC Complementary Medicine and Therapies

Fig. 4

From: Transcutaneous Neuromodulation improved inflammation and sympathovagal ratio in patients with primary biliary ssscholangitis and inadequate response to Ursodeoxycholic acid: a pilot study

Fig. 4

Modulation of Fecal Bile Acid Metabolism. a Comparison of fecal BAs in the PBC (pretreatment P1–10) to the control group (C1–10). b Comparison of fecal BAs in the PBC group before (P1–10) and after TN (P1.1–10.1) and the control group (C1–10). After TN combined with UDCA, bile acids had no significant change to pretreatment. The color bars look similar. b Comparison of fecal BAs in the PBC group before (P1–10) and after sham-TN (P1.1–10.1) and the control group (C1–10). After Sham TN combined with UDCA, bile acids had no significant change to pretreatment. The color bars look similar. After statistical analysis, there were no significant changes in fecal BAs. The color bars in three heatmap were also look similar. It indicated no obvious changes in the metabolism of fecal bile acids after TN combined with UDCA visually

Back to article page
\